Automated description from the Alliance of Genome Resources (Release 8.3.0)
Predicted to enable long-chain fatty acid binding activity and long-chain fatty acid transmembrane transporter activity. Acts upstream of or within several processes, including lipid droplet formation; response to food; and triglyceride biosynthetic process. Predicted to be located in apical cortex and microvillus. Predicted to be active in cytosol and nucleus. Is expressed in embryo endoderm; gut; liver and biliary system; and skeletal muscle. Human ortholog(s) of this gene implicated in alcoholic liver cirrhosis; cerebrovascular disease (multiple); coronary artery disease; end stage renal disease; and obesity. Orthologous to human FABP2 (fatty acid binding protein 2).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.